BMSTC Member Sue Doughty is mentioned in the article - "Sue Doughty lives in Twyford, Berkshire. She has multiple sclerosis. She faced homelessness and had to rely on help from her daughter.
Following a year spent in appeal, the Court of Tribunal awarded Sue PIP ongoing for life."
Source MS Society:
Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.
Source MS Trust:
We often focus solely on our physical health but looking after our mental health is also vital to our sense of wellbeing. Jo Johnson, a consultant neuropsychologist with a special interest in MS, introduces practical steps you can take to improve and maintain your mental wellbeing.
Source ITV Meridian News:
Multiple Sclerosis is a condition that affects more than 1100,000 people in the UK but the MS Society claims that it's becoming more difficult for sufferers to claim disability benefit.
The charity is highlighting the case of a trainee veterinary nurse...
Source Miranda's MS Blog:
Miranda is an MS Specialist Nurse based in Bedford, she writes a blog to share things she has found good, useful or positive within the MS community.
Source MS Trust:
As today is Festival of Sleep Day, we're talking sleep and MS. Poor sleep is common in people with multiple sclerosis, with about 50% of people reported to experience some form of sleep disturbance.
Source Radio Times:
Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his...
Source Multiple Sclerosis News Today:
Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy,...
Source Mutiple Sclerosis News Today:
In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.